may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.

send petitions, emails, or tweets to world leaders. call governments or join rallies. we offer a variety of ways to make your voice heard..

�the kind of review being proposed does not, at least initially, appear to bring anything new or needed to is already a robust system of oversight,� mogulof said in the statement..